MSD
A senior technical lead within the Biologics Drug Substance Commercialization (BDSC) team focused on downstream purification, responsible for advancing late-stage clinical and commercial biologics processes toward commercialization and licensure. The role partners across functions and external collaborators to support process development, characterization, technology transfer, and regulatory documentation for biologics drug substance manufacturing.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Principal Researcher, Downstream Process Development - Biologics
Eisai
Process Development Senior Scientist - Pivotal Biologics Drug Substance Technology
Amgen
Principal Research Scientist II
AbbVie
Associate Scientist
Sanofi
Scientist, Downstream Process Development
avidbio
Research Associate II
Vir Biotechnology